112 related articles for article (PubMed ID: 16522544)
21. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
Rieux-Laucat F
Curr Dir Autoimmun; 2006; 9():18-36. PubMed ID: 16394653
[TBL] [Abstract][Full Text] [Related]
22. The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance.
Turbyville JC; Rao VK
Autoimmun Rev; 2010 May; 9(7):488-93. PubMed ID: 20170754
[TBL] [Abstract][Full Text] [Related]
23. Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation.
Sleight BJ; Prasad VS; DeLaat C; Steele P; Ballard E; Arceci RJ; Sidman CL
Bone Marrow Transplant; 1998 Aug; 22(4):375-80. PubMed ID: 9722073
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
Bleesing JJ; Straus SE; Fleisher TA
Pediatr Clin North Am; 2000 Dec; 47(6):1291-310. PubMed ID: 11130997
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune lymphoproliferative syndrome in a patient with common variable immunodeficiency: dichotomy of apoptosis.
Narra MB; Abdou NI
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):585-8. PubMed ID: 17601274
[TBL] [Abstract][Full Text] [Related]
26. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
Price S; Shaw PA; Seitz A; Joshi G; Davis J; Niemela JE; Perkins K; Hornung RL; Folio L; Rosenberg PS; Puck JM; Hsu AP; Lo B; Pittaluga S; Jaffe ES; Fleisher TA; Rao VK; Lenardo MJ
Blood; 2014 Mar; 123(13):1989-99. PubMed ID: 24398331
[TBL] [Abstract][Full Text] [Related]
27. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease.
Peters AM; Kohfink B; Martin H; Griesinger F; Wörmann B; Gahr M; Roesler J
Exp Hematol; 1999 May; 27(5):868-74. PubMed ID: 10340403
[TBL] [Abstract][Full Text] [Related]
28. A new disorder of lymphocyte apoptosis: combination of autoimmunity, infectious lymphadenopathy, double negative T cells, and impaired activation-induced cell death.
Hundt M; Posovszky C; Schmidt RE
Immunobiology; 2002 Dec; 206(5):514-8. PubMed ID: 12607726
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune lymphoproliferative syndrome type III: an indefinite disorder.
Van Der Werff Ten Bosch J; Otten J; Thielemans K
Leuk Lymphoma; 2001 Mar; 41(1-2):55-65. PubMed ID: 11342357
[TBL] [Abstract][Full Text] [Related]
30. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
31. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
Neven B; Magerus-Chatinet A; Florkin B; Gobert D; Lambotte O; De Somer L; Lanzarotti N; Stolzenberg MC; Bader-Meunier B; Aladjidi N; Chantrain C; Bertrand Y; Jeziorski E; Leverger G; Michel G; Suarez F; Oksenhendler E; Hermine O; Blanche S; Picard C; Fischer A; Rieux-Laucat F
Blood; 2011 Nov; 118(18):4798-807. PubMed ID: 21885602
[TBL] [Abstract][Full Text] [Related]
32. Pathological findings in human autoimmune lymphoproliferative syndrome.
Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
[TBL] [Abstract][Full Text] [Related]
33. Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome.
Lim WK; Ursea R; Rao K; Buggage RR; Suhler EB; Dugan F; Chan CC; Straus SE; Nussenblatt RB
Am J Ophthalmol; 2005 Mar; 139(3):562-3. PubMed ID: 15767081
[TBL] [Abstract][Full Text] [Related]
34. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune lymphoproliferative syndrome associated with severe humoral immunodeficiency and monoclonal gammopathy.
Nanan R; Ströbel P; Haas JP; Marx A; Kreth HW
Ann Hematol; 2002 Jun; 81(6):332-5. PubMed ID: 12107564
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
Rieux-Laucat F; Le Deist F; Fischer A
Cell Death Differ; 2003 Jan; 10(1):124-33. PubMed ID: 12655301
[TBL] [Abstract][Full Text] [Related]
37. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
[TBL] [Abstract][Full Text] [Related]
38. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Oliveira JB; Bleesing JJ; Dianzani U; Fleisher TA; Jaffe ES; Lenardo MJ; Rieux-Laucat F; Siegel RM; Su HC; Teachey DT; Rao VK
Blood; 2010 Oct; 116(14):e35-40. PubMed ID: 20538792
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
Zhu S; Hsu AP; Vacek MM; Zheng L; Schäffer AA; Dale JK; Davis J; Fischer RE; Straus SE; Boruchov D; Saulsbury FT; Lenardo MJ; Puck JM
Hum Genet; 2006 Apr; 119(3):284-94. PubMed ID: 16446975
[TBL] [Abstract][Full Text] [Related]
40. How I treat autoimmune lymphoproliferative syndrome.
Rao VK; Oliveira JB
Blood; 2011 Nov; 118(22):5741-51. PubMed ID: 21885601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]